CONGRESS NEWS

Highlights in gynaecological cancers

After last year’s ESMO meeting in Munich, the recent ESMO Congress in Barcelona again proved to be a ‘grand cru’ in gynaecological cancer, with the confirmation of the role of maintenance therapy with PARP inhibitors in first-line therapy of advanced ovarian cancer, even beyond BRCA mutation. Additionally, recent progress in the management of endometrial and cervical cancer will be highlighted in this overview.

Highlights in melanoma

The introduction of immune checkpoint inhibitors highly impacted the treatment landscape of melanoma over the last decade. At ESMO 2019, several abstracts again proved the clinical potential of these agents in the treatment of melanoma, both in (neo)adjuvant as in the advanced setting. In addition to this, promising results were presented with talimogene laherparepvec in early and in metastatic melanoma. Finally, several abstracts also discussed combinations of targeted agents and immunotherapy in patients with advanced melanoma.

2019 World Conference on Lung Cancer

SUMMARY

From 7–10th of September, the 2019 World Conference on Lung Cancer (WCLC) again proved to be the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. The meeting attracted more than 7,000 specialists from more than 100 countries. In this highlight report ten top abstracts presented at the meeting will be discussed. For a more complete coverage of the meeting we refer to the congress website: https://wclc2019.iaslc.org.

(BELG J MED ONCOL 2019;13(7):309–13)

EAU19: New developments in PCa imaging and trials

SUMMARY

The European Association of Urology (EAU) held its 34th Annual Congress in Barcelona from the 15–19th of March, a recurring highlight for the Association and for urology in general. While the presenting of the latest EAU Guidelines, holding meetings for its Board and Sections and setting agendas for the coming year are essential to the running of the Association, it is the latest scientific developments in urology that took centre stage in Barcelona.

Scientific Congress Office Chairman Prof Arnulf Stenzl (DE) presided over the scientific programme one last time, stepping down to join the EAU Executive as Adjunct Secretary General (Science). He was congratulated on his track record and particularly the comprehensive and diverse five-day programme that greeted the nearly 12,000 participants from 127 countries in Barcelona.

This article provides some uro-oncological highlights from the 263 different scientific sessions at EAU19. For the most complete coverage, see the on-site news reports on www.eau19.org/news.

(BELG J MED ONCOL 2019;13(7):314–6)

Highlights of the 2019 annual meeting of the European Neuroendocrine Tumour Society (ENETS)

MARCH 6-8TH, 2019, BARCELONA

Highlights in melanoma

ASCO 2019 featured the presentation of several interesting studies in patients with metastatic melanoma. In addition to this, new data in the (neo)-adjuvant setting were presented.

Highlights in genitourinary cancers

From June 1^st till June 5^th, Chicago was host for the 55^th annual ASCO meeting. This report will highlight the most important studies concerning genitourinary cancers presented during the meeting.